Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected p...

by Masahiro Fukuoka, Yi Long Wu, Sumitra Thongprasert, Patrapim Sunpaweravong, Swan Swan Leong, Virote Sriuranpong, Tsu Yi Chao, Kazuhiko Nakagawa, Da Tong Chu, Nagahiro Saijo
Published 2018